Brief: Taro Reports Qtrly Loss Per Share $0.50
July 27 (Reuters) - Taro Pharmaceutical Industries Ltd
TARO.N :
* TARO PROVIDES RESULTS FOR QUARTER ENDED JUNE 30, 2021
* QUARTERLY LOSS PER SHARE $0.50
* QUARTERLY SALES ROSE 25.1 PERCENT TO $147.1 MILLION
* QUARTERLY EARNINGS PER SHARE $1.09 EXCLUDING ITEMS
Source text for Eikon: ID:nBw8vCcVCa
Further company coverage: TARO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma